Mycobacterium Tuberculosis Detection Compositions for Targeted PCR
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting Mycobacterium tuberculosis (MTB) are time-consuming, insensitive, and non-specific, particularly in low-income countries, leading to inadequate case detection and rising multi-drug resistant strains, with only 60% global case detection and less than 20% of MDR-MTB cases being appropriately diagnosed.
Innovation Solution
A nucleic acid amplification method using specific primer pairs (SEQ ID NOs: 1 and 2, and SEQ ID NOs: 3 and 4) and probes (SEQ ID NOs: 5 and 6) for detecting MTB in samples, combined with inactivation reagents like isopropanol and sodium hydroxide, followed by real-time PCR to enhance sensitivity and specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If routine cultures are used for MTB detection, then detection can be performed, but the process is time-consuming and can take up to six weeks
Solution Approach 1:
The patent replaces the traditional mechanical culture method with a molecular biology-based nucleic acid amplification system (PCR). This substitution enables detection within hours rather than weeks, resolving the contradiction between detection accuracy and detection time by using a fundamentally different detection mechanism that does not require waiting for bacterial growth.
2Speed
If microscopic examination of acid-fast smears is used, then rapid detection is achieved, but the method is insensitive and non-specific
Solution Approach 1:
The patent merges the speed advantage of microscopic examination with the sensitivity and specificity of molecular methods by using nucleic acid amplification followed by detection. This combination achieves rapid detection (within hours) while simultaneously providing high sensitivity and specificity through targeted amplification of MTB genomic sequences, resolving the contradiction between speed and measurement precision.
3Measurement precision
If molecular tests are developed to improve case detection, then sensitivity and specificity increase, but the cost and complexity increase
Solution Approach 1:
The patent segments the detection system into distinct functional modules: sample preparation, nucleic acid extraction, PCR amplification with specific primers and probes, and detection. This segmentation allows each component to be optimized independently and enables modular implementation that can be adapted to different resource settings, reducing overall system complexity while maintaining high detection accuracy.
Solution Approach 2:
The patent uses specific parameter changes in the form of uniquely designed primer and probe sequences that target MTB-specific genomic regions. By changing the molecular parameters (nucleotide sequences) rather than the fundamental detection approach, the system achieves high specificity and sensitivity without requiring complex equipment or procedures.
4Measurement precision
If more comprehensive testing is performed to detect MDR-MTB, then diagnostic accuracy improves, but the percentage of cases appropriately diagnosed remains low at 19%
Solution Approach 1:
The patent performs preliminary identification of MTB infection using nucleic acid amplification before proceeding to drug susceptibility testing. This preliminary action allows for rapid triage of cases, enabling healthcare systems to prioritize and process MDR-MTB testing more efficiently, thereby improving both diagnostic accuracy and overall case detection productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high sensitivity (93%) and specificity (97%) in detecting MTB, especially in smear-negative samples, reducing false negatives and false positives, and is suitable for high-throughput automated detection.
Implementation Method 1
hybridizing a probe to the nucleic acid sequence complementary to the target sequence so as to form a hybrid comprising the probe and the nucleic acid sequence complementary to the target sequence
Implementation Method 2
subjecting the mixture to amplification conditions to generate at least one copy of a nucleic acid sequence complementary to the target sequence
Implementation Method 3
inactivation reagents like isopropanol and sodium hydroxide
Implementation Method 4
inactivation reagents like isopropanol and sodium hydroxide
Data Source
Figure 1
Figure 2~3
Figure 4
AI summary
Provided herein are compositions and methods useful for the detection of MTB. In particular, provided herein are kits, reagents, reaction mixtures, and methods involving such for nucleic acid amplification and detection procedures, which specifically and sensitively detect MTB in samples.